Ondansetron Labatec, 4mg/2ml, concentré pour perfusion

7680594350014 CH-59435 Infusionskonzentrat
Ondansetron Labatec, 4mg/2ml, concentré pour perfusion
Ondansetron Labatec, 4mg/2ml, concentré pour perfusion
1 / 2
google

Article details

Package size
5x2ml
Selling units
10
Measure
Ampulle(n)
Galenic form
Infusionskonzentrat
Galenic group
Lösbar zur Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
05/01/2024
Summary of Product Characteristics
Français
05/01/2024
Summary of Product Characteristics
Italien
05/01/2024

Detailed composition

Substance Quantity Type Category
(N/A)
4.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
7.2 MG Substance HBESI

Reimbursement information

Public price
CHF 50.00
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/12/2018

Authorization holder

Labatec Pharma SA

1217 Meyrin

Authorization information

Swissmedic authorization number
59435
Drug name
Ondansetron Labatec, concentré pour perfusion
Galenic form
KOIN
ATC Code
A04AA01
Authorization status
Z
Dispensing category
B
First authorization
03/02/2010
Authorization expiration date
31/12/9999
IT Number
01.09.0.
Domain
Human medicine

Package details

Description (FR)
ONDANSETRON Labatec conc perf 4 mg/2ml 5 amp 2 ml
Description (DE)
ONDANSETRON Labatec Inf Konz 4 mg/2ml 5 Amp 2 ml
Market launch
03/02/2010
Narcotic (BTM)
No

Original drug

Zofran, Filmtabletten
GTIN: 7680507100330
CHF 45.05
View original

Other package sizes (1)

ONDANSETRON Labatec conc perf 8 mg/4ml 5 amp 4 ml
5x4ml AMP
GTIN: 7680594350038
View